Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Unraveling the Molecular Changes that Drive the Repression of the Unfolded Protein Response with Ageing

UCUPA

What defines the functional specialization of a cell is its unique proteome. Proteins need to be translated and properly folded to ensure their biological function. Several protein quality control pathways have arisen during evolution, some of them specialized in monitoring protein folding in specific organelles . As a result of ageing, animals...

Funding Programme
Start Date
End Date
Total Funding
€ 212 934
European Countries Involved

Unravelling ApoE4 contribution to tau-mediated synaptic degeneration in AD by combining advanced proteomics and super resolution microscopy

SynApoE

Alzheimers disease (AD) is one of the biggest scientific and socio-economic challenges of the 21st century. Currently, there is no cure. Aggregates of amyloid- and tau protein, along with neuroinflammation/gliosis, are hallmarks of AD that lead to synaptic and neuronal loss as the basis for cognitive decline. The latter correlates closely with the...

Funding Programme
Start Date
End Date
Total Funding
€ 1 498 449
European Countries Involved

Unravelling the impact of nucleosome arrays on condensin by implementing an in-vitro chromatin-loop extrusion assay

ConNuc

The three-dimensional organization of chromosomal DNA is essential for critical genomic functions, including chromosome segregation, gene expression, and DNA damage repair. Structural Maintenance of Chromosomes (SMC) complexes, such as cohesin, the Smc5/6 complex, and condensin, are integral to preserving chromosomal architecture and supporting...

Funding Programme
Start Date
End Date
Total Funding
€ 217 965
European Countries Involved

Unravelling White Matter Biological Heterogeneity for the Prediction of AD

WHY-AD

White matter (WM) is being increasingly studied in Alzheimer’s disease (AD) as a possible key pathological driver. In-vivo, WM health can be measured through several metrics derived from diffusion weighted imaging (DWI). While these metrics provide information about the WM micro- and macro-structural alterations, the biological processes...

Funding Programme
Start Date
End Date
Total Funding
€ 193 643
European Countries Involved

Unveiling human astrocyte states, functions and their contribution to Alzheimer´s disease

hASTROCURE

The pathogenesis of Alzheimer´s disease (AD) is not fully understood and no cure is available so far. Current therapeutic targets are insufficient and there is an urgent need for finding new pathways and mechanisms and novel targets to treat this terrible disease. Due to critical species-specific differences and the limitations of rodent models of...

Funding Programme
Start Date
End Date
Total Funding
€ 1 999 875
European Countries Involved

UpSurgeOn Academy: A multilevel educational platform for neurosurgical training.

UpSurgeOn Academy

UpSurgeOn is an Italian SME established in 2017, by Neurosurgeons for Neurosurgeons, with a focus on creating a educational platform composed by different educational apps, training and simulation devices actually in the Neurosurgical arena. We have 15 employees, including a combination of neurosurgeons, software developers, technicians and...

Funding Programme
Start Date
End Date
Total Funding
€ 71 429
European Countries Involved

Validation of a fast and simple peripheral blood diagnostic biomarker kit for Alzheimer’s disease

ADDIA

The French SME Amoneta Diagnostics has previously developed a diagnostic kit for Alzheimer’s disease (AD) based on two blood biomarkers that are scientifically proven to be associated with AD. The company holds the intellectual property for specific fluorescent probes that can detect these biomarkers in small amounts of blood using flow cytometry....

Funding Programme
Start Date
End Date
Total Funding
€ 4 998 625
European Countries Involved

Vascular and Aymloid Predictors of Neurodegeneration and Cognitive Decline in Nondemented Subjects

VASCAMY

Alzheimer’s disease (AD) is the most frequent cause of dementia that affects one in 14 persons over the age 65 years and one in six persons over the age of 80 years. Increased deposition of the protein beta-amyloid (Aß) is a core brain pathology of AD that occurs years before the onset of clinical symptoms of dementia. Together with Aß...

Funding Programme
Start Date
End Date
Total Funding
€ 100 000
European Countries Involved

Vascular Dementia: revealing the detrimental synergy between hypertension, micro-strokes and Neuro-Vascular Decoupling"

VD&NVD

Research in recent years has started to provide an alternative view to Alzheimer's etiology emphasizing the role of other factors such as inflammation and brain vascular alterations in the development of Alzheimer. Of major interest is the link between AD and hypertension, another global epidemic affecting millions of people worldwide. Hypertension...

Funding Programme
Start Date
End Date
Total Funding
€ 100 000
European Countries Involved

Vascular Engineering on chip using differentiated Stem Cells

VESCEL

Organs-on-chip hold great promise for the creation of complex and realistic disease models while having the potential to refine, reduce and (partly) replace existing animal models (3R principle). Of all organs, vasculature is extremely well-suited to realize on-chip since it pervades the whole organism, is present in all other organs, its...

Funding Programme
Start Date
End Date
Total Funding
€ 2 250 000
European Countries Involved

VELES Excellence Hub - Strengthening the South-East Europe Smart Health Regional Excellence and Boosting the Innovation Potential

VELES

Smart Health is EU Strategic Value Chain that contributes to growth, jobs and competitiveness. Health Data is the main enabler for the value chain, but it also depends on cutting edge technologies - AI, cloud computing, IoT, to integrate the dispersed knowledge and support innovative healthcare solutions and services. EC sets the creation of a...

Funding Programme
Start Date
End Date
Total Funding
€ 4 750 000
European Countries Involved

Virtual and memory adaptable spaces creating stimuli for the senses in ageing people with dementia

SENSE-GARDEN

There are 47 million people living with dementia worldwide and expected to increase to 131 million by 2050. A person with dementia experiences loss of function, especially memory, eventually affecting verbal communication and ultimately creating disconnection from the close ones such as family and friends. The SENSE-GARDEN project will create rooms...

Funding Programme
Start Date
End Date
Total Funding
€ 2 100 000
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).